Publications

Peer-reviewed journal articles

85. Lamy F. R., Daniulaityte R., Barratt M. J., Lokala U., Sheth A. & Carlson R. G., “Etazene, safer than heroin and fentanyl”: Non-fentanyl novel synthetic opioid listings on one darknet market. Drug and Alcohol Dependence, 225, 108790. doi: 10.1016/j.drugalcdep.2021.108790 [PDF]

84. Jauffret-Roustide, M., Barratt, M., de Dinechin, S., Davies, E., Gilchrist, G., Hughes, C., Maier, L., Ferris, J., & Winstock, A. (2020). Consommation d’alcool et d’autres produits psychoactifs pendant la pandémie de COVID-19 dans la Global Drug Survey : une perspective française [Consumption of Alcohol and Other Psychoactive Drugs during the COVID-19 Pandemic in the Global Drug Survey: A French Perspective]. Psychotropes, 26(2), 209-219. doi: 10.3917/psyt.262.0209 [PDF]

83. Engel, L. B., Bright, S. J., Barratt, M. J., & Allen, M. M. (2020, accepted 13/10/20). Positive drug stories: possibilities for agency and positive subjectivity for harm reduction. Addiction Research and Theory. doi: 10.1080/16066359.2020.1837781 [PDF]

82. Puljević, C., Zahnow, R., Benfer, I., Winstock, A. R., Maier, L. J., Barratt, M. J., & Ferris, J. (2020). Patterns of methamphetamine production among an international sample of methamphetamine ‘cooks’. Drug and Alcohol Review. doi: 10.1111/dar.13205 [PDF]

81. Ross, A., Potter, G. R., Barratt, M. J., & Aldridge, J. A. (2020). ‘Coming out’: Stigma, reflexivity and the drug researcher’s drug use. Contemporary Drug Problems. doi: 10.1177/0091450920953635 [PDF]

80. Barratt, M. J., & Aldridge, J. (2020). No magic pocket: Buying and selling on drug cryptomarkets in response to the COVID-19 pandemic and social restrictions. International Journal of Drug Policy, 83, Article 102894. doi: 10.1016/j.drugpo.2020.102894 [PDF]

79. Petranker, R., Anderson, T., Maier, L., Barratt, M.J., Ferris, J., & Winstock, A. (2020, epub 8 Oct). Microdosing psychedelics: Subjective benefits and challenges, substance testing behavior, and the relevance of intention. Journal of Psychopharmacology. doi: 10.1177/0269881120953994 [PDF]

78. Lamy, F. R., Daniulaityte, R., Barratt, M. J., Lokala, U., Sheth, A., & Carlson, R. G. (2020). Listed for sale: Analyzing data on fentanyl, fentanyl analogs and other novel synthetic opioids on one cryptomarket. Drug and Alcohol Dependence, 213, Article 108115. [PDF]

77. Kumar, N., Puljević, C., Ferris, J., Winstock, A., & Barratt, M. J. (2020). The intersection between spliff usage, tobacco smoking, and having the first joint after waking. Scientific Reports, 10(1), 7650. [FINAL]

76. Connolly, D., Davies, E., Lynskey, M., Barratt, M. J., Maier, L., Ferris, J., Winstock, A., & Gilchrist, G. (2020). Comparing intentions to reduce substance use and willingness to seek help among transgender and cisgender participants from the Global Drug Survey. Journal of Substance Abuse Treatment, 112, 86-91. [PDF]

75. Palamar, J. J., Salomone, A., & Barratt, M. J. (2020). Drug checking to detect fentanyl and new psychoactive substances. Current Opinion in Psychiatry, 33, 301-305. [PDF]

74. Childs, A., Coomber, S., Bull, M., & Barratt, M. J. (2020). Evolving and diversifying selling practices on drug cryptomarkets: An exploration of off-platform ‘direct dealing’. Journal of Drug Issues, 50, 173-190. [PDF]

73. Martin, J., Munksgaard, R., Coomber, R., Demant, J., & Barratt, M. J. (2020). Selling drugs on darkweb cryptomarkets: differentiated pathways, risks and rewards. British Journal of Criminology, 60, 559-578. [PDF]

72. Palamar, J. J., Acosta, P., Sutherland, R., Shedlin, M. G., & Barratt, M. J. (2019). Adulterants and altruism: A qualitative investigation of “drug checkers” in North America. International Journal of Drug Policy, 74, 160-169. [PDF]

71. Sznitman, S., Barratt, M., Decorte, T., Hakkarainen, P., Lenton, S., Potter, G.,  Werse, B., & Wilkins, C. (2019). Do medical cannabis growers attempt to produce cannabis with different cannabinoid concentrations than recreational growers? Drugs and Alcohol Today, 19(4), 251-256. doi: 10.1108/DAT-06-2019-0021 [PDF]

70. Valente, H., Martins, D., Carvalho, H., Pires, C. V., Carvalho, M. C., Pinto, M., & Barratt, M. J. (2019). Evaluation of a drug checking service at a large scale electronic music festival in Portugal. International Journal of Drug Policy, 73, 88-95. [PDF]

69. Kumar, N., Puljević, C., Ferris, J., Winstock, A., & Barratt, M. J. (2019). Cannabis use patterns at the dawn of US cannabis reform. Journal of Cannabis Research, 1(5). doi: 10.1186/s42238-019-0003-z [FINAL]

68. Kowalski, M., Hooker, C., & Barratt, M. J. (2019). Should we smoke it for you as well? An ethnographic analysis of a drug cryptomarket environment. International Journal of Drug Policy, 73, 245-254. doi: 10.1016/j.drugpo.2019.03.011 [PDF]

67. Decorte, T., Malm, A., Sznitman, S., Hakkarainen, P., Barratt, M. J., Potter, G., Werse, B., Kamphausen, G., Lenton, S., & Frank, V. A. (2019). The challenges and benefits of analyzing feedback comments in surveys: Lessons from a cross-national online survey of small-scale cannabis growers. Methodological Innovations, 12(1). [FINAL]

66. Palamar, J. J. & Barratt, M. J. (2019). Prevalence of reagent test-kit use and perceptions of purity among ecstasy users in an electronic dance music scene in New York City. Drug and Alcohol Review, 38, 42-49. [PDF]

65. Moyle, L., Childs, A., Coomber, R., & Barratt, M. J. (2019). #Drugsforsale: An exploration of the use of social media and encrypted messaging apps to supply and access drugs. International Journal of Drug Policy, 63, 101-110. [PDF]

64. Fernández Calderón, F., Díaz Batanero, C., Barratt, M. J., & Palamar, J. J. (2019). Harm reduction strategies related to dosing and their relation to harms among festival attendees who use multiple drugs. Drug and Alcohol Review, 38, 57-67.

63. Banister, S., Adams, A., Richard, K., MacDonald, C., Glass, M., Boyd, R., Connor, M., McGregor, I., Havel, C., Bright, S., Ventura, M., Gil, C., Barratt, M., & Gerona, R. (2019). Synthesis and pharmacology of synthetic cannabinoid 5FCUMYL-P7AICA, a scaffold hopping analogue of 5F-CUMYLPICA and 5F-CUMYL-PINACA. Drug Testing and Analysis, 11, 279-291. [PDF]

62. Hakkarainen, P., Decorte, T., Sznitman, S., Karjalainen, K., Barratt, M. J., Frank, V., Lenton, S., Potter, G., Werse, B., & Wilkins, C. (2019). Examining the blurred boundaries between medical and recreational use of cannabis – Results from an international study of small-scale cannabis cultivation. Drugs: Education, Prevention and Policy, 26, 250-258. [PDF]

61. Barratt, M. J., Latimer, J., Jauncey, M., Tay, E., & Nielsen, S. (2018). Urine drug screening for early detection of unwitting use of fentanyl and its analogues among people who inject heroin in Sydney, Australia. Drug and Alcohol Review, 37, 847-850. [PDF]

60. Grigg, J., Barratt, M. J., & Lenton, S. (2018). Drug detection dogs at Australian outdoor music festivals: Deterrent, detection and iatrogenic effects. International Journal of Drug Policy, 60, 89-95. [PDF]

59. Lenton, S., Frank, V. A., Barratt, M. J., Potter, G. R. & Decorte, T. (2018). Growing practices and the use of potentially harmful chemical additives among a sample of small-scale cannabis growers in three countries. Drug and Alcohol Dependence, 192, 250-256. [PDF]

58. Grigg, J., Barratt, M. J., & Lenton, S. (2018). Double dropping down under: Correlates of simultaneous consumption of two ecstasy pills in a sample of Australian outdoor music festival attendees. Drug and Alcohol Review, 37, 851-855. [PDF]

57. Raubenheimer, J. E., & Barratt, M. J. (2018). Digital era drug surveillance—Quo vadis, Australia? [Editorial]. Drug and Alcohol Review, 37, 693-696. [PDF]

56. Sutherland, R., Peacock, A., Roxburgh, A., Barratt, M. J., Burns, L., Bruno, R. (2018). Typology of new psychoactive substance use among the general Australian population. Drug and Alcohol Dependence, 188, 126-134. [PDF]

55. Benfer, I., Zahnow, R., Barratt, M. J., Maier, L, Winstock, A., & Ferris, J. (2018). The impact of drug policy liberalisation on willingness to seek help for problem drug use: a comparison of 20 countries. International Journal of Drug Policy, 56, 162-175. [PDF]

54. Hughes, C. E., Barratt, M. J., Ferris, J. A., Maier, L., & Winstock, A. R. (2018). Drug-related policy encounters across the globe: How do they compare? International Journal of Drug Policy, 56, 197-207. [PDF]

53. Demant, D., Oviedo-Trespalacios, O., Carroll, J.-A., Ferris, J. A., Maier, L. J., Barratt, M. J., & Winstock, A. R. (2018). Do people with intersecting identities report more high risk alcohol use and lifetime substance use? International Journal of Public Health, 63, 621-630. [PDF]

52. Barratt, M. J., Bruno, R., Ezard, N., & Ritter, A. (2018). Pill testing or drug checking in Australia: Acceptability of service design features. Drug and Alcohol Review, 37, 226–236. [Q1; IF 2.789]. Cited in the Victorian Inquiry into Drug Law Reform 2018 (pp. 511-512). [PDF]

51. Aldridge, J., Stevens, A., & Barratt, M. J. (2018). For debate: Will growth in cryptomarket drug buying increase the harms of illicit drugs? Addiction, 113, 789-796. Article shortlisted for EMCDDA Scientific Award 2018. [FINAL]

50. Lawn, W., Hallak, J. E., Crippa, J. A., Santos, R. D., Porffy, L., Barratt, M. J., Ferris, J. A., Winstock, A. R., & Morgan, C. J. A. (2017). Well-being, problematic alcohol consumption and acute subjective drug effects in ayahuasca users: A large, international, online survey. Scientific Reports, 7. Article no. 15201. [PDF]

49. Lloyd, B., Zahnow, R., Barratt, M., Best, D., Lubman, D., Ferris, J. (2017). Exploring mortality among drug treatment clients: the relationship between treatment type and mortality. Journal of Substance Abuse Treatment, 82, 22-28. [PDF]

48. Palamar, J. J., Barratt, M. J., Coney, L., & Martins, S. S. (2017). Current synthetic cannabinoid use among high school seniors. Pediatrics, 140(4), e20171330. [PDF]

47. Daniulaityte, R., Lamy, F. R., Barratt, M. J., Nahhas, R. W., Martins, S. S., Boyer, E. W., Sheth, A., & Carlson, R. G. (2017). Characterizing marijuana concentrate users: A web-based survey. Drug and Alcohol Dependence, 178, 399–407. [PDF]

46. Barratt, M. J., Ferris, J. A., Zadhow, R., Palamar, J. J., Maier, L. J., & Winstock, A. R. (2017). Moving on from representativeness: Testing the utility of the Global Drug Survey. Substance Abuse: Research and Treatment, 11. doi: 10.1177/1178221817716391 [PDF]

45. Lamy, F., Daniulaityte, R., Nahhas, R. W., Barratt, M. J., Sheth, A., Smith, G. A., Martins, S. S., Boyer, E. W., & Carlson, R. J. (2017).  Increases in synthetic cannabinoids-related harms: results from a longitudinal web-based content analysis. International Journal of Drug Policy, 44, 121–129. [PDF]

44. Martins, D., Barratt, M. J., Vale Pires, C., Carvalho, H., Ventura, M., Fornís, I., & Valente, H. (2017). The detection and prevention of unintentional consumption of DOx and 25x-NBOMe at Boom Festival. Human Psychopharmacology: Clinical and Experimental. doi: 10.1002/hup.2608. [PDF]

43. Coney, L., Maier, L., Ferris, J. R., Winstock, A. R. & Barratt, M. J. (2017). Genie in a blotter: A comparative study of LSD and LSD analogues’ effects and user profile. Human Psychopharmacology: Clinical and Experimental. doi: 10.1002/hup.2599 [PDF]

42. Sutherland, R., Barratt, M. J., Peacock, A., Dietze, P., Breen, C., Burns, L., Bruno, R. (2017). New psychoactive substances: Purchasing and supply patterns in Australia. Human Psychopharmacology: Clinical and Experimental. doi: 10.1002/hup.2577 [PDF]

41. Anderson, L. S., Bell, H. G., Gilbert, M., Davidson, J., Winter, C., Barratt, M. J., Win, B., Painter, J. L., Menone, C., Sayegh, J., & Dasgupta, N. (2017). Using social listening data to monitor misuse and nonmedical use of Bupropion: A content analysis. JMIR Public Health and Surveillance, 3(1): e6. doi: 10.2196/publichealth.6174 [FINAL]

40. Barratt, M. J., Seear, K., & Lancaster, K. (2017). A critical examination of the definition of ‘psychoactive effect’ in Australian drug legislation. International Journal of Drug Policy, 40, 16–25. Cited in the Victorian Inquiry into Drug Law Reform 2018 (p. 278). [PDF]

39. Sutherland, R., Bruno, R., Peacock, A., Lenton, S., Matthews, A., Salom, C., Dietze, P., Butler, K., Burns, L., & Barratt, M. J. (2017). Motivations for new psychoactive substance use among regular psychostimulant users in Australia. International Journal of Drug Policy, 43, 23–32. [PDF]

38. Scott, J., Grigg, J., Barratt, M. J., & Lenton, S. (2017). Social capital and cannabis supply. Journal of Sociology, 53(2), 382–397. [PDF]

37. Barratt, M. J., & Maddox, A. (2016). Active engagement with stigmatised communities through digital ethnography. Qualitative Research, 16, 701–719. [PDF]

              Reprinted in K. Hughes, J. Coulton, J. Goodwin, & J. Hughes (Eds.), 2017, Contemporary approaches to ethnographic research (pp. TBC). Sage. 

36. Palamar, J. J., Barratt, M. J., Ferris, J. A., & Winstock, A. R. (2016). Correlates of new psychoactive substance use among a self-selected sample of nightclub attendees in the United States. The American Journal on Addictions, 25, 400–407. [PDF]

35. Barratt, M. J., & Aldridge, J. (2016). Everything you always wanted to know about drug cryptomarkets* (*but were afraid to ask) [Editorial for special issue]. International Journal of Drug Policy, 35, 1–6. [PDF]

34. Barratt, M. J., Ferris, J. A., & Winstock, A. R. (2016). Safer scoring? Cryptomarkets, threats to safety and interpersonal violence. International Journal of Drug Policy, 35, 24–31. [PDF]

33. Caudevilla, F., Ventura, M., Fornís, I., Barratt, M. J., lladanosa, C. G., Quintana, P., Vidal, C., Muñoz, A., & Calzada, N. (2016). Results of an international drug testing service for cryptomarket users. International Journal of Drug Policy, 35, 38–41. [PDF]

32. Barratt, M. J., Maddox, A., Lenton, S., & Allen, M. (2016). ‘What if you live on top of a bakery and you like cakes?’ – Exploring the drug use and harm trajectories before, during and after the emergence of Silk Road. International Journal of Drug Policy, 35, 50–57. [PDF]

31. Butterfield, R. J., Barratt, M. J., Ezard, N., & Day, R. O. (2016). Drug checking to improve the monitoring of new psychoactive substances in Australia. Medical Journal of Australia, 204 (4), 144–145. [PDF]

30. Maddox, A., Barratt, M. J., Allen, M., & Lenton, S. (2016). Constructive activism in the dark web: Cryptomarkets and illicit drugs in the digital ‘demimonde’. Information, Communication and Society, 19, 111–126. [PDF]

29. Lenton, S., Grigg, J., Scott, J., Barratt, M., & Eleftheriadis, D. (2015). The social supply of cannabis among young people in Australia. Trends and Issues in Crime and Criminal Justice, No. 503.

28. Barratt, M. J., Potter, G., Wouters, M., Wilkins, C., Werse, B., Perälä, J., Pederson, M., Nguyen, H., Malm, A., Lenton, S., Korf, D., Klein, A., Heyde, J., Hakkarainen, P., Frank, V., Decorte, T., Bouchard, M., & Blok, T. (2015). Lessons from conducting trans-national Internet-mediated participatory research with hidden populations of cannabis cultivators. International Journal of Drug Policy, 26, 238–249. [PDF]

27. Potter, G. R., Barratt, M. J., Malm, A., Bouchard, M., Blok, T., Christensen, A.-S., Decorte, T., Frank, V. A., Hakkarainen, P., Klein, A., Lenton, S., Perälä, J., Werse, B., & Wouters, M. (2015). Global patterns of domestic cannabis cultivation: Sample characteristics and patterns of growing across eleven countries. International Journal of Drug Policy, 26, 226–237. [PDF]

              Reprinted in B. Werse & C. Bernard (Eds.), 2016, Friendly business: International views on social supply, self-supply and small-scale drug dealing (pp. 163-196). Stuttgart, Germany: Springer VS. 

26. Barratt, M. J. & Lenton, S. (2015). Representativeness of online purposive sampling with Australian cannabis cultivators. International Journal of Drug Policy, 26, 323–326. [PDF]

25. Lenton, S., Frank, V. A., Barratt, M. J., Dahl, H. V., & Potter, G. (2015). Attitudes of cannabis growers to regulation of cannabis cultivation under a non-prohibition cannabis model. International Journal of Drug Policy 26, 257–266. [PDF]

24. Hakkarainen, P., Frank, V. A., Barratt, M. J., Dahl, H. V., Decorte, T., Karjalainen, K., Lenton, S., Potter, G., & Werse, B. (2015). Growing medicine: Small-scale cannabis cultivation for medical purposes in six different countries. International Journal of Drug Policy, 26, 250–256. [PDF]

23. Barratt, M. J., Ferris, J. A., & Lenton, S. (2015). Hidden populations, online purposive sampling, and external validity: Taking off the blindfold. Field Methods, 27, 3–21. [PDF]

22. Barratt, M. J., Allen, M., & Lenton, S. (2014). ‘PMA sounds fun’: Negotiating drug discourses online. Substance Use and Misuse, 49, 987­–998.  [PDF]

21. Barratt, M. J., Livingston, M., Matthews, S., & Clemens, S. (2014). Gaming machine density is correlated with rates of help-seeking for problem gambling: A local area analysis in Victoria, Australia. Journal of Gambling Issues, 29. doi: 10.4309/jgi.2014.29.16

20.  Lawn, W., Barratt, M., Williams, M., Horne, A., & Winstock, A. (2014). The NBOMe hallucinogenic drug series: Patterns of use, characteristics of users and self-reported effects in a large international sample. Journal of Psychopharmacology, 28, 780–788. [PDF]

19.  Barratt, M. J., Ferris, J. A., & Winstock, A. R. (2014). Use of Silk Road, the online drug market-place, in the UK, Australia and the USA. Addiction, 109, 774–783. [PDF]

18. Winstock, A. R. & Barratt, M. J. (2013). The 12-month prevalence and nature of adverse experiences resulting in emergency medical presentations associated with the use of synthetic cannabinoid products. Human Psychopharmacology: Clinical and Experimental, 28, 390–393. [PDF]

17. Lloyd, B., Barratt, M. J., Ferris, J., Best, D., & Lubman, D. I. (2013). Factors influencing mortality among alcohol and drug treatment clients in Victoria, Australia: The role of demographic and substance use characteristics. Australian and New Zealand Journal of Psychiatry, 47, 859–867. [PDF]

16. Chiauzzi, E., DasMahapatra, P., Lobo, K., & Barratt, M. J. (2013). Participatory research with an online drug forum: A survey of user characteristics, information sharing, and harm reduction views. Substance Use and Misuse, 48, 661–670. [PDF]

15. Winstock, A. R., & Barratt, M. J. (2013). Synthetic cannabis: A comparison of patterns of use and effect profile with natural cannabis in a large global sample. Drug and Alcohol Dependence, 131, 106–111. [PDF]

14. Bright, S. J., Bishop, B., Kane, R., Marsh, A., & Barratt, M. J. (2013). Kronic Hysteria: Exploring the intersection between Australian synthetic cannabis legislation, the media, and drug-related harm. International Journal of Drug Policy, 24, 231–237. [PDF]

              Reprinted in Inciardi, J. A., & McElrath, K. (Eds.). (2014). The American Drug Scene: Readings in a global context (7th ed., pp. 57–68). New York: Oxford University Press.

13. Barratt, M. J., Lenton, S., & Allen, M. (2013). Internet content regulation, public drug websites and the growth in hidden Internet services. Drugs: Education, Prevention and Policy, 20, 195–202. [PDF]

12. Barratt, M. J., Cakic, V., & Lenton, S. (2013). Patterns of synthetic cannabinoid use in Australia. Drug and Alcohol Review, 32, 141-146. [PDF]

11. Barratt, M. J., Bouchard, M., Decorte, T., Frank, V. A., Hakkarainen, P., Lenton, S., Malm, A., Nguyen, H., & Potter, G. R. (2012). Understanding global patterns of domestic cannabis cultivation. Drugs and Alcohol Today, 12, 213-221. [PDF]

10. Barratt, M. J. (2012). The efficacy of interviewing young drug users through online chat. Drug and Alcohol Review, 31, 566-572. [PDF]

9.    Hunter, B., Lubman, D. I., & Barratt, M. J. (2011). Alcohol and drug misuse in the elderly. Australian and New Zealand Journal of Psychiatry, 45, 343.

8.    Barratt, M. J., & Lenton, S. (2010). Beyond recruitment? Participatory online research with people who use drugs. International Journal of Internet Research Ethics, 3, 69-86. [PDF]

7.    Livingston, M., Matthews, S., Barratt, M. J., Lloyd, B., & Room, R. (2010). Diverging trends in alcohol consumption and alcohol-related harm in Victoria. Australian and New Zealand Journal of Public Health, 34, 368-373.

6.    Nielsen, S., & Barratt, M. J. (2009). Prescription drug misuse: Is technology friend or foe? Drug and Alcohol Review, 28, 81-86.

5.    Dietze, P. M., Cvetkovski, S., Barratt, M. J., & Clemens, S. (2008). Patterns and incidence of gamma-hydroxybutyrate (GHB)-related ambulance attendances in Melbourne, Victoria. Medical Journal of Australia, 188, 709-711.

4.    Barratt, M. J., Norman, J. S., & Fry, C. L. (2007). Positive and negative aspects of participation in illicit drug research: Implications for recruitment and ethical conduct. International Journal of Drug Policy, 18, 235-238. [PDF]

3.    Johnston, J., Barratt, M. J., Fry, C. L., Kinner, S., Stoové, M., Degenhardt, L., George, J., Jenkinson, R., Dunn, M. & Bruno, R. (2006). A survey of regular ecstasy users’ knowledge and practices around determining pill content and purity: Implications for policy and practice. International Journal of Drug Policy, 17, 464-472. 

2.    Chanteloup, F., Lenton, S., Fetherston, J., & Barratt, M. J. (2005). Expected impacts of the Cannabis Infringement Notice scheme in Western Australia on regular users and their involvement in the cannabis market. Drug and Alcohol Review, 24, 311-319.

1.    Barratt, M. J., Chanteloup, F., Lenton, S., & Marsh, A. (2005). Cannabis law reform in Western Australia: An opportunity to test theories of marginal deterrence and legitimacy. Drug and Alcohol Review, 24, 321-330.

Book chapters

8.  Shortis, P., Aldridge, J., & Barratt, M. J. (2020). Drug cryptomarket futures: Structure, function and evolution in response to law enforcement actions. In D. Bewley-Taylor & C. Hallam (Eds.), Research Handbook on International Drug Policy (pp. 355–380). Edward Elgar. doi: 10.4337/9781788117067.00031 [PDF]

7.  Barratt, M. J., Aldridge, J., & Maddox, A. (2018). Dark web. In B. Warf (Ed.), The Sage Encyclopedia of the Internet. Thousand Oaks, CA: Sage. doi: 10.4135/9781473960367.n59 [PDF]

6.  Barratt, M. J., & Lenton, S. (2017). Drugs and the internet. In A. Ritter, T. King & N. Lee (Eds.), Drug use in Australian society (2nd ed.) (pp. 102-123). Melbourne: Oxford University Press. [PDF]

5.  Lenton, S., Grigg, J., Scott, J., & Barratt, M. (2016). The social supply of cannabis in Australia – Definitional challenges and regulatory possibilities. In B. Werse & C. Bernard (Eds.), Friendly business: International views on social supply, self-supply and small-scale drug dealing (pp. 29-46). Stuttgart, Germany: Springer VS.   

4.  Barratt, M. J., & Lenton, S. (2013). Drugs and the internet. In A. Ritter, T. King, & M. Hamilton (Eds.), Drug use in Australian society (pp. 272-293). South Melbourne: Oxford University Press.

3.  Dwyer, R., Pennay, A., Green, R., Siokou, C., Barratt, M., Thomson, N., & Moore, D. (2012). The social contexts and cultural meanings of ATS use and their implications for policy and practice. In S. Allsop & N. Lee (Eds.), Perspectives on Amphetamine-Type Stimulants (pp. 56-68). Melbourne: I.P. Communications.

2.  Wodak, A., Ryan, J., Griffiths, P., van Beek, I., Barratt, M. J., Lenton, S., Dolan, K., Rodas, A., Noller, G., & Farrell, M. (2012). Policy and practice in harm reduction in Australasia. In R. Pates & D. Riley (Eds.), Harm reduction in substance use and high-risk behaviour: International policy and practice (1st ed.) (pp. 405-423). Chichester, UK: Wiley-Blackwell. [PDF]

1.  Barratt, M. J. (2011). Discussing illicit drugs in public internet forums: Visibility, stigma, and pseudonymity. In J. Kjeldskov & J. Paay (eds), C&T ‘11. Proceedings of the Fifth International Conference on Communities and Technologies, Brisbane, Australia (pp. 159-168). New York, NY: ACM. doi:10.1145/2103354.2103376

Letters, commentaries and book reviews in peer-reviewed journals

13.  Barratt, M. J., Kowalski, M., Volpe, I., & Maier, L. J. (2020). On-site drug checking can provide quantitative analysis [commentary]. Internal Medicine Journal, 50, 1022-1023. [PDF]

12.  Aldridge, J., Stevens, A., & Barratt, M. J. (2018). Harms, benefits and the policing of cryptomarkets: a response to commentaries. Addiction, 113, 802-804. [PDF]

11.  Vidal Giné, C., Ventura Vilamala, M., Measham, F., Brunt, T. M., Bücheli, A., Paulos, C., Valente, H., Martins, D., Libois, B., Tögel-Lins, K., Jones, G., Karden, A., & Barratt, M. J. (2017). The utility of drug checking services as monitoring tools and more: A response to Pirona et al. [commentary]. International Journal of Drug Policy, 45, 46-47. [PDF]

10.  Barratt, M. J. & Ritter, A. (2017). Commentary on Vrolijk et al. (2017): The paradox of the quality control problem [invited commentary]. Addiction, 112, 101-102. [PDF]

9.  Barratt, M. J. (2017). Bluelight.org: A harm-reduction community that supports public health research [letter to the editor]. Journal of Substance Use, 22, 1-2. [PDF]

8.  Palamar, J. J. & Barratt, M. J. (2016). Synthetic cannabinoids: Undesirable alternatives to natural marijuana [invited commentary]. American Journal of Drug and Alcohol Abuse, 42(4), 371-373. [PDF]

7.  Barratt, M. J., & Ezard, N. (2016). Drug checking interventions can track the nature and size of the discrepancy between self-report and actual drugs consumed [letter to the editor]. Addiction, 111, 558-559. [PDF]

6.  Barratt, M. J., & Ezard, N. (2015 Jul 10). Response to ‘A bolt out of the blue: the night of the blue pills’. Medical Journal of Australia. [FINAL]

5.  Barratt, M. J. (2015). Drugs on the dark net: How cryptomarkets are transforming the global trade in illicit drugs [book review]. Drug and Alcohol Review, 34(4), 458-459. [PDF]

4.  Barratt, M. J. (2013). Negotiating ethical challenges in youth research [book review]. Youth Studies Australia, 32(4), 72-73.

3.  Caldicott, D. G. E., Bright, S. J., & Barratt, M. J. (2013). NBOMe – A very different kettle of fish [letter to the editor]. Medical Journal of Australia, 199 (5): 1. doi: 10.5694/mja13.10926 [PDF]

2.  Barratt, M. J. (2012). Markets, methods and messages. Dynamics in European drug research [book review]. Drug and Alcohol Review, 31, 826-827.

1.  Barratt, M. J. (2012). Silk Road: eBay for drugs [letter to the editor]. Addiction, 107, 683. [PDF]